Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹8.67 Cr₹48 Cr₹16 Cr₹-36 Cr₹-40 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA is ₹8.67 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹8.67 Cr
Mar2023₹48 Cr
Mar2022₹16 Cr
Mar2021₹-36 Cr
Mar2020₹-40 Cr

How is Deferred Tax Assets / Liabilities of MANKIND PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹8.67 Cr
-81.76
Mar2023 ₹48 Cr
191.02
Mar2022 ₹16 Cr
Positive
Mar2021 ₹-36 Cr
Negative
Mar2020 ₹-40 Cr -

Compare Deferred Tax Assets / Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹101,363.4 Cr 2.4% 7.1% 3.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,155.0 Cr -3.9% 3% 7.9% Stock Analytics
DIVIS LABORATORIES ₹147,295.0 Cr -5% -1.1% 71.6% Stock Analytics
CIPLA ₹116,664.0 Cr -4.4% 0.2% -1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,678.0 Cr -1.6% 6.5% 26.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,162.6 Cr -2.4% 2.4% -5.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.4%

7.1%

3.9%

SENSEX

-2.5%

1.9%

4.9%


You may also like the below Video Courses